Sam Sherman is an associate in the antitrust group in Axinn’s Washington, DC office. His practice focuses on antitrust transactions, litigation, and government investigations. He has represented both U.S. and multinational clients across a variety of sectors, including life sciences, technology, and cannabis.
Sam earned his JD at Stanford Law School. While at Stanford Law School, he was awarded the John Hart Ely Prize for Outstanding Performance in Lawyering for Innovation in Artificial Intelligence, and he also earned two Gerald Gunther Prizes for Outstanding Performance in Communications Law. Sam was a summer associate with Axinn in 2019.
Prior to law school, he was a Research Fellow at Stanford University, where he used cutting-edge social scientific methods to study difficult questions of law and public policy and co-authored two articles about improving government service delivery based on empirical evidence. Sam holds a BA in Mathematics and Economics from Wake Forest University, where he was a Nancy Susan Reynolds Scholar and recipient of the David and Lelia Farr Prize for Excellence in Economics (awarded to one graduating economics major for outstanding achievement).
**Not yet admitted to the Washington, DC Bar.
- Antitrust Litigation is Coming to Cannabis, Cannabis Business Executive, May 25, 2022
- Big Trouble for Biglari Under the HSR Act – and Why Cannabis Operators Should Take Note, Cannabis Business Executive, March 2, 2022
- Cost and Opportunity in Suspending Early Merger Clearances, Law360, February 8, 2021
- JD – Stanford Law School (2020)
- BA, summa cum laude – Wake Forest University (2015)